Edinburgh-based Hearing Diagnostics Limited has received £715,000 of investment which will enable its hearing test system to undergo trials with universities and hearing aid retailers in the UK with a view to full market launch in 2021.
Alongside the Archangels investment, Hearing Diagnostics is proposing a number of board appointments. Charles Sweeney, formerly CEO of Bloxx and Document Outsourcing Group and a non-executive director of a number of tech businesses, will join Hearing Diagnostics as Chairman. Jacqui McLaughlin, CEO of Archangels portfolio company, Reactec, and Phil Harris PhD, CEO of Vert Rotors, will join the board as non-executive directors.
Read more HERE.
